Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
  This Article

 

Abstract

 

Full-text

 

Table of contents
  Comments

 

Letters

 

Comments to Editor

 

e-mail Alert
  Sign Up

 

Original Research Article


 

In vitro Anti-Leishmanial and Anti-Tumour Activities of a Pentacyclic Triterpenoid Compound Isolated from the Fruits of Dregea volubilis Benth Asclepiadaceae

 

Biswas Moulisha1*, Mandal Nirup Bikash2, Palit Partha2, Ghosh Ashoke Kumar3, Bannerjee Sukdeb2 and Haldar Pallab.Kanti4

1Bengal Institute of Pharmaceutical Sciences, Kalyani, Nadia-741 235, 2Indian Institute of Chemical Biology, Department of Steroids and Terpenoids Chemistry, Jadavpur-700 032, ,3Bengal School of Technology, Delhi Road, Sugandha, Dt. Hooghly, PIN: 712 102, 4Division of Pharmacology, Department of Pharmaceutical Technology, Jadavpur University, Kolkata - 700 032, West Bengal, India. E-mail: moulisha_biswas@yahoo.co.in  Tel: +91-33-25211273; +91-9831354803(M); Fax: +91-33-25891742 

Received: 16 September 2008                                                                               Revised accepted: 5 January 2008

Tropical Journal of Pharmaceutical Research, April 2009; 8(2): 127-131

Abstract

 

Purpose: Dregea volubilis Benth, commonly known as Jukti in Bengal, is used in the treatment of boils and abscesses from ancient times. The purpose of this study is to elucidate the active compounds and as well as their anti-leishmanial and anti-tumour activities.              

Methods: Dried and crushed fruits of Dregea volubilis were extracted by petroleum ether (40 - 60°C); the best solvent system had first been verified by analytical Thin Layer Chromatography (TLC). The extract was subjected to TLC and column chromatography (CC) to isolate the pure compounds. Spectra data were obtained by Infra Red pectroscopy, Mass Spectroscopy and Nuclear Magnetic Resonance - Proton Magnetic Resonance (PMR), Carbon Magnetic Resonance (CMR) and Distortionless Enhancement by Polarization Transfer (DEPT) - for structure elucidation of the isolated compound(s). One of the compounds isolated was screened for anti-leishmanial activity against promastigotes of Leishmania donovani and anti-tumour activity on K562 leukemic cell line.

Results: A pentacyclic triterpenoid compound was isolated and designated as taraxerone, and then characterized as d-friedoolean-14-en, 3 one together with ß-sitosterol and a long chain lipid fraction.. This compound showed in vitro anti-leishmanial activity against promastigotes of Leishmania donovani (strain AG 83) and anti-tumour activity on K562 leukemic cell line.

Conclusion: A pentacyclic triterpenoid compound designated as taraxerone and characterized as D-friedoolean-14-en, 3 one together was successfully isolated. The structure was determined on the basis of spectral analysis (IR, MASS, NMR (PMR, CMR and DEPT) and the compound demonstrated in vitro anti-leishmanial and anti-tumour activities.

 

Keywords: Dregea volubilis, Pentacyclic triterpenoid, Taraxerone, Spectroscopy (IR, MASS, CMR, PMR, DEPT), Anti-leishmanial, Anti-tumour.

Copyright@2002-2013. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net